The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Haresh Kapurlal Mehta
MEDICO · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 5.9 pts more than Nifty Microcap 250 and 5.1 pts more than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Haresh Kapurlal Mehta, a promoter of Medico Remedies Ltd, sold 1,00,000 equity shares (0.12% of total share capital) through an open market transaction on 28 March 2025. As a result, his shareholding in the company declined from 1,72,29,200 shares (20.76%) to 1,71,29,200 shares (20.64%). The disclosure was filed under Regulation 29(2) of SEBI's Takeover Regulations. The total equity share capital of the company remains at 8,29,84,000 shares of Rs. 2 each, worth Rs. 16.59 crore. The sale is small in size and the promoter's overall stake remains comfortable at over 20%.
This is a minor promoter sell-off (only 0.12% of equity) and is unlikely to meaningfully affect the stock price or signal any major concern. The promoter continues to hold a significant 20.64% stake, so long-term confidence in the company remains largely intact.